GlaxoSmithKline

The Central Consumer Protection Authority (CCPA) has imposed a penalty of Rs 10 lakh each on Glaxo Smith Kline and Naaptol for misleading advertisements of their products.

GlaxoSmithKline Pharmaceuticals on Friday said its net profit increased 3 per cent to Rs 193 crore in the second quarter ended September. The drug maker had reported a net profit from continuing operations at Rs 187 crore in the July-September period of the previous fiscal. However, revenue from operations declined to Rs 906 crore in the second quarter of the current fiscal compared to Rs 916 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing. "GSK India has delivered another quarter of strong performance in general medicines and specialty business, gaining market share. We hope to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth," GlaxoSmithKline Pharmaceuticals Managing Director Sridhar Venkatesh said. Vaccines business was impacted due to low vaccination rates as the overall market for the self-pay segment in which the company operates continues to decline, he ...

Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices

Drug manufacturers GlaxoSmithKline on Monday said its consolidated net profit increased to Rs 116 crore in the first quarter. Shares of the company closed at Rs 1,726.20 on BSE, said reports

Unilever sees 2022 underlying sales growth of 4.5%-6.5%, announces 3-bn euro buyback

The proposed deal involves the transfer of GlaxoSmithKline Asia Pvt Ltd's products and GSK Consumer Brands (indirectly) to GSK CH HoldCo

Sotrovimab, developed with Vir, tested in lab, on hamsters; key mutations of Omicron did not elude drug activity in study

Advent International, CVC Capital Partners and KKR are among potential suitors for GSK's consumer unit

Drug firm GlaxoSmithKline Pharmaceuticals on Monday reported a 9.24 per cent rise in consolidated net profit to Rs 121.08 crore for the quarter ended June 30, 2021.

Treatment with Sotrovimab resulted in an 85 per cent reduction in the risk of hospitalization, says company.

Pharma giant is talking with the UK and other governments about building facilities to bring vaccine development onshore before the next crisis.

If the results are conclusive, the two drugmakers hope to see the vaccine approved by the fourth quarter after having initially targeted the first half of this year

GlaxoSmithKline Pharmaceuticals on Friday said it has registered a consolidated net profit of Rs 156.51 crore for the third quarter ended December

UnitedHealth Group is promoting former GlaxoSmithKline leader Sir Andrew Witty to become the health insurance provider's next CEO immediately.

Sanofi and GSK have signed a Statement of Intent with Gavi, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual Covid-19 vaccines.

This is already a record year for amount mobilised through the equity capital markets (ECM), topping $31.2 billion raised during calendar 2007, according to financial data firm Refinitiv

The group's most advanced project is with French partner Sanofi and the two have said they hope to get approval for their candidate next year

The Cambridge, Massachusetts, biotech's $1.5-billion deal pays out in full if its vaccine receives regulatory clearance by January 31, 2021

The US government previously gave Moderna around $1 billion to fund its research efforts, bringing total US funding to around $2.5 billion

Multiple myeloma is the second most common form of blood cancer in the US and is generally considered treatable, but not curable